Literature DB >> 561856

Influence of dietary fat on the induction of mammary tumors by N-nitrosomethylurea: associated hormone changes and differences between Sprague-Dawley and F344 rats.

P C Chan, J F Head, L A Cohen, E L Wynder.   

Abstract

A single iv dose of N-nitrosomethylurea (NMU, 50 mg/kg) given to 50-day-old F344 and Sprague-Dawley rats was sufficient to induce mammary adenocarcinomas. The Sprague-Dawley rats were more sensitive to the carcinogenic action of NMU than were the F344 rats. Moreover, regardless of strain, tumors developed in greater numbers and with a shorter latent period in animals fed a high-fat (HF) diet compared with animals fed a low-fat (LF) diet. The tumor-enhancing effect of HF diet was not related to body weight, since the mean body weight of the rats on the two diets was similar. In addition, no correlation was found between body weight and tumor incidence in individual rats under either dietary regimen. Since the most pronounced difference in tumor incidence between groups fed HF and LF diets was exhibited by the F344 rats, hormone analyses were performed on this group. At termination of the experiment, prolactin levels in the group fed an HF diet were significantly higher than those in the group fed an LF diet. Total estrogen levels were also significantly higher in the group fed an HF diet, compared with the group fed an LF diet, but this difference was seen only at the metestrus-diestrus stage. Regardless of diet or estrous cycle, when animals with tumors were compared with those without tumors, the former exhibited higher prolactin-estrogen (P/E) ratios. The results suggested a relationship between the ingestion of high levels of dietary fat, a high P/E ratio, and increased mammary tumor incidence.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 561856     DOI: 10.1093/jnci/59.4.1279

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

Review 1.  Strategies for cancer prevention through diet modification.

Authors:  P Greenwald; L Light; S S McDonald; H R Stern
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  Personal habits.

Authors:  E L Wynder
Journal:  Bull N Y Acad Med       Date:  1978-04

Review 3.  Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?

Authors:  Denise K Reaves; Erika Ginsburg; John J Bang; Jodie M Fleming
Journal:  Endocr Relat Cancer       Date:  2015-01-26       Impact factor: 5.678

4.  The influence of dietary medium chain triglycerides on rat mammary tumor development.

Authors:  L A Cohen; D O Thompson
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

5.  Dietary polyunsaturated fat versus saturated fat in relation to mammary carcinogenesis.

Authors:  K K Carroll; G J Hopkins
Journal:  Lipids       Date:  1979-02       Impact factor: 1.880

Review 6.  Timing of dietary fat exposure and mammary tumorigenesis: role of estrogen receptor and protein kinase C activity.

Authors:  L Hilakivi-Clarke; R Clarke
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Isolation and characterization of a serially cultivated, neoplastic, epithelial cell line from the N-nitrosomethylurea induced rat mammary adenocarcinoma.

Authors:  L A Cohen
Journal:  In Vitro       Date:  1982-06

Review 8.  Effects of fatty acids on gap junctional communication: possible role in tumor promotion by dietary fat.

Authors:  C F Aylsworth; C W Welsch; J J Kabara; J E Trosko
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

9.  Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin.

Authors:  T Narisawa; P Hermanek; M Habs; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 10.  Perinatal factors increase breast cancer risk.

Authors:  L Hilakivi-Clarke; R Clarke; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.